Literature DB >> 31302421

Herbs-partitioned moxibustion improves intestinal epithelial tight junctions by upregulating A20 expression in a mouse model of Crohn's disease.

Yin Shi1, Yajing Guo2, Jing Zhou3, Luyi Wu4, Liu Chen5, Yi Sun6, Tao Li7, Jimeng Zhao8, Chunhui Bao9, Huangan Wu10.   

Abstract

BACKGROUND: To investigate effects moxibustion exerts on A20 expression and regulation of intestinal epithelial tight junctions via the TNF-α-NF-κB-MLCK pathway in Crohn's disease (CD).
METHODS: C57BL/6 wild type (WT) and A20IEC-KO mice (48 each) were randomly divided into normal control (NC), model control (MC), mesalazine (MESA) and herbs-partitioned moxibustion (HPM) groups (12 mice per group). An experimental model of CD was established using 2, 4, 6 trinitrobenzene sulfonic acid. MESA and HPM mice were treated with MESA and HPM (at Tianshu (ST25) and Qihai (CV6)), respectively. In HPM group, moxa cones (0.5 cm in diameter and 0.3 cm in height) made of refined mugwort floss were placed on herbal cakes (medicinal formula dispensing [radix] Aconiti praeparata, [cortex] Cinnamomi, etc.) at Tianshu (ST25) and Qihai (CV6) and ignited. The moxa cones were ignited, and two moxa cones were used for each treatment once daily for 10 days. In MESA group, mice were fed MESA, which was prepared at a proportion of 1:0.0026, twice daily for 10 days.
RESULTS: Intestinal epithelial ultrastructure of WT HPM mice improved more than A20IEC-KO HPM mice compared to MC mice. WT HPM mice exhibited greater expression of A20 compared with MC mice (P < 0.01). TNF-α, NF-kB p65, MLCK, MLC, TRAF6 and RIP1 levels in A20IEC-KO and WT HPM mice were all decreased compared to MC mice (Pall < 0.01). NF-κB p65MLCK and TRAF6 levels were increased in A20IEC-KO HPM mice as compared to WT HPM mice (Pall < 0.05). Intestinal epithelial levels of occludin, claudin-1, ZO-1 and F-actin increased in all HPM mice (Pall  < 0.01-0.05), while occludin, claudin-1, and ZO-1 levels were lower in A20 IEC-KO HPM mice (P < 0.05, P < 0.01, P < 0.01).
CONCLUSION: HPM downregulates abnormal activation of the TNF-α-NF-κB-MLCK pathway by upregulating expression of A20 in a mouse model of CD, thereby protecting intestinal epithelial tight junctions and repairing the damage CD causes to the intestinal epithelial barrier.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  A20; Crohn’s disease; Herbs-partitioned moxibustion; Intestinal epithelial barrier; TNF-α-NF-κB-MLCK pathway

Mesh:

Substances:

Year:  2019        PMID: 31302421     DOI: 10.1016/j.biopha.2019.109149

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  [WDSUB1 knockdown alleviates dextran sulfate sodium-induced colitis in mice by inhibiting nuclear factor-κB signaling pathway].

Authors:  S Wang; L Cui; X Liu; Z Luo; H Li; J Pu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

Review 2.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

3.  Herbal cake-partitioned moxibustion inhibits colonic autophagy in Crohn's disease via signaling involving distinct classes of phosphatidylinositol 3-kinases.

Authors:  Shi-Yuan Wang; Ji-Meng Zhao; Ci-Li Zhou; Han-Dan Zheng; Yan Huang; Min Zhao; Zhi-Ying Zhang; Lu-Yi Wu; Huan-Gan Wu; Hui-Rong Liu
Journal:  World J Gastroenterol       Date:  2020-10-21       Impact factor: 5.742

4.  LncRNA-miRNA-mRNA Network Analysis Reveals the Potential Biomarkers in Crohn's Disease Rats Treated with Herb-Partitioned Moxibustion.

Authors:  Xue-Jun Wang; Xiao-Ying Li; Xiao-Cong Guo; Li Liu; You-You Jin; Yun-Qiong Lu; Yao-Jia-Ni Cao; Jun-Yi Long; Huan-Gan Wu; Dan Zhang; Guang Yang; Jue Hong; Yan-Ting Yang; Xiao-Peng Ma
Journal:  J Inflamm Res       Date:  2022-03-05

5.  Herb-Partitioned Moxibustion Improves Crohn's Disease-Associated Intestinal Fibrosis by Suppressing the RhoA/ROCK1/MLC Pathway.

Authors:  Min Zhao; Zhijun Weng; Yan Huang; Handan Zheng; Dong Han; Jiacheng Shen; Rong Huang; Huirong Liu; Luyi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-17       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.